Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes

Journal of Autoimmunity

Volumn 36, Issue 2, 2011, Pages 155-160

  Ge, Xinhui ^a,b   James, Eddie A ^a   Reijonen, Helena ^a,b   Kwok, William W ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antigen presentation; HLA DQ8; HLA DR4; Type 1 Diabetes

Indexed keywords

AUTOANTIGEN; DEATH RECEPTOR 4; EPITOPE; GLUTAMATE DECARBOXYLASE 65; HLA DQ8 ANTIGEN; HLA DR ANTIGEN; HLA DR0401; HLA DR0403; HLA DR0405; INSULIN; UNCLASSIFIED DRUG;

ARTICLE; DISEASE PREDISPOSITION; DISSOCIATION; GENETIC ASSOCIATION; HALF LIFE TIME; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; KINETICS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STABILITY;

AMINO ACID SEQUENCE; AUTOANTIGENS; BINDING, COMPETITIVE; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; EPITOPES; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INSULIN; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING;

EID: 79951946714     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.12.004     Document Type: Article

References (32)

1. Castano L., Eisenbarth G.S. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990, 8:647-679.
2. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994, 15(4):516-542.
3. Rood P.P., Bottino R., Balamurugan A.N., Fan Y., Cooper D.K., Trucco M. Facilitating physiologic self-regeneration: a step beyond islet cell replacement. Pharm Res 2006, 23(2):227-242.
4. Wagener D.K., Sacks J.M., LaPorte R.E., Macgregor J.M. The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 1982, 31(2):136-144.
5. Warram J.H., Krolewski A.S., Gottlieb M.S., Kahn C.R. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984, 311(3):149-152.
6. Rich S.S. Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 1990, 39(11):1315-1319.
7. Concannon P., Erlich H.A., Julier C., Morahan G., Nerup J., Pociot F., et al. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1435 multiplex families. Diabetes 2005, 54(10):2995-3001.
8. Todd J.A., Bell J.I., McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987, 329(6140):599-604.
9. Morel P.A., Dorman J.S., Todd J.A., McDevitt H.O., Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A 1988, 85(21):8111-8115.
10. Monos D.S., Mickelson E., Hansen J.A., Baker L., Zmijewski C.M., Kamoun M. Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus. Hum Immunol 1988, 23(4):289-299.
11. Sheehy M.J., Scharf S.J., Rowe J.R., Neme de Gimenez M.H., Meske L.M., Erlich H.A., et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989, 83(3):830-835.
12. Wen L., Chen N.Y., Tang J., Sherwin R., Wong F.S. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest 2001, 107(7):871-880.
13. Undlien D.E., Friede T., Rammensee H.G., Joner G., Dahl-Jorgensen K., Sovik O., et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997, 46(1):143-149.
14. Cucca F., Lampis R., Frau F., Macis D., Angius E., Masile P., et al. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Hum Immunol 1995, 43(4):301-308.
15. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57(4):1084-1092.
16. Nepom G.T. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 1990, 39(10):1153-1157.
17. Canaday D.H., Gehring A., Leonard E.G., Eilertson B., Schreiber J.R., Harding C.V., et al. T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing. J Immunol Methods 2003, 281(1-2):129-142.
18. Ge X., Piganelli J.D., Tse H.M., Bertera S., Mathews C.E., Trucco M., et al. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility. Diabetes 2006, 55(12):3455-3462.
19. Novak E.J., Liu A.W., Nepom G.T., Kwok W.W. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J Clin Invest 1999, 104(12):R63-R67.
20. Gaudebout P., Zeliszewski D., Golvano J.J., Pignal C., Le Gac S., Borras-Cuesta F., et al. Binding analysis of 95 HIV gp120 peptides to HLA-DR1101 and -DR0401 evidenced many HLA-class II binding regions on gp120 and suggested several promiscuous regions. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14(2):91-101.
21. Hausmann D.H., Yu B., Hausmann S., Wucherpfennig K.W. pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH. J Exp Med 1999, 189(11):1723-1734.
22. Joshi R.V., Zarutskie J.A., Stern L.J. A three-step kinetic mechanism for peptide binding to MHC class II proteins. Biochemistry 2000, 39(13):3751-3762.
23. Wicker L.S., Chen S.L., Nepom G.T., Elliott J.F., Freed D.C., Bansal A., et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 1996, 98(11):2597-2603.
24. Herman A.E., Tisch R.M., Patel S.D., Parry S.L., Olson J., Noble J.A., et al. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif. J Immunol 1999, 163(11):6275-6282.
25. Lee K.H., Wucherpfennig K.W., Wiley D.C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001, 2(6):501-507.
26. Lieberman S.M., DiLorenzo T.P. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 2003, 62(5):359-377.
27. Marshall K.W., Liu A.F., Canales J., Perahia B., Jorgensen B., Gantzos R.D., et al. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J Immunol 1994, 152(10):4946-4957.
28. Ettinger R.A., Liu A.W., Nepom G.T., Kwok W.W. Exceptional stability of the HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus. J Immunol 1998, 161(11):6439-6445.
29. Kawasaki E., Eguchi K. Is type 1 diabetes in the Japanese population the same as among Caucasians?. Ann N Y Acad Sci 2004, 1037:96-103.
30. Murao S., Makino H., Kaino Y., Konoue E., Ohashi J., Kida K., et al. Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes 2004, 53(10):2684-2690.
31. Kawabata Y., Ikegami H., Kawaguchi Y., Fujisawa T., Shintani M., Ono M., et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 2002, 51(2):545-551.
32. Levisetti M.G., Lewis D.M., Suri A., Unanue E.R. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice. Diabetes 2008, 57:1852.